Exousia Bio, Inc. Deferred Tax Assets, Valuation Allowance
Exousia Bio, Inc. (LMMY) had Deferred Tax Assets, Valuation Allowance of $0 as of 2026-02-28, per its 10-Q filed 2026-06-16.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-06-16
- 2026-02-28: Deferred Tax Assets, Valuation Allowance $0.00.
- 2025-11-30: Deferred Tax Assets, Valuation Allowance $0.00.
- 2025-08-31: Deferred Tax Assets, Valuation Allowance $0.00.
- 2025-05-31: Deferred Tax Assets, Valuation Allowance $17.46K.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2026-02-28 | $0.00 10-Q · filed 2026-06-16 |
| 2025-11-30 | $0.00 10-Q · filed 2026-03-17 |
| 2025-08-31 | $0.00 10-Q · filed 2025-11-17 |
| 2025-05-31 | $17.46K 10-K · filed 2025-10-17 |
| 2025-02-28 | $717.00 10-Q · filed 2025-04-24 |
| 2024-11-30 | $717.00 10-Q · filed 2025-01-10 |
| 2024-08-31 | $17.46K 10-Q · filed 2024-10-11 |
| 2024-05-31 | $17.46K 10-K · filed 2024-08-30 |
| 2024-02-29 | $16.36K 10-Q · filed 2024-04-15 |
| 2023-11-30 | $15.35K 10-Q · filed 2024-01-16 |
| 2023-08-31 | $14.60K 10-Q · filed 2023-10-11 |
| 2023-05-31 | $12.04K 10-K · filed 2023-09-01 |
| 2023-02-28 | $6.42K 10-Q · filed 2023-05-08 |